Karumanchi SA - Search Results

1

Circulating lymphangiogenic factors in preeclampsia.

Lely AT, Salahuddin S, Holwerda KM, Karumanchi SA, Rana S. Lely AT, et al. Among authors: karumanchi sa. Hypertens Pregnancy. 2013;32(1):42-9. doi: 10.3109/10641955.2012.697953. Epub 2012 Sep 7. Hypertens Pregnancy. 2013. PMID: 22957504 Free PMC article.

2

Circulating angiogenic factors in the pathogenesis and prediction of preeclampsia.

Lam C, Lim KH, Karumanchi SA. Lam C, et al. Among authors: karumanchi sa. Hypertension. 2005 Nov;46(5):1077-85. doi: 10.1161/01.HYP.0000187899.34379.b0. Epub 2005 Oct 17. Hypertension. 2005. PMID: 16230516 Review.

3

In vivo rat model of preeclampsia.

Karumanchi SA, Stillman IE. Karumanchi SA, et al. Methods Mol Med. 2006;122:393-9. doi: 10.1385/1-59259-989-3:393. Methods Mol Med. 2006. PMID: 16511996

4

Angiogenic factors and preeclampsia.

Tjoa ML, Levine RJ, Karumanchi SA. Tjoa ML, et al. Among authors: karumanchi sa. Front Biosci. 2007 Jan 1;12:2395-402. doi: 10.2741/2241. Front Biosci. 2007. PMID: 17127249 Review.

5

Mapping the theories of preeclampsia and the role of angiogenic factors: a systematic review.

Widmer M, Villar J, Benigni A, Conde-Agudelo A, Karumanchi SA, Lindheimer M. Widmer M, et al. Among authors: karumanchi sa. Obstet Gynecol. 2007 Jan;109(1):168-80. doi: 10.1097/01.AOG.0000249609.04831.7c. Obstet Gynecol. 2007. PMID: 17197602 Review.

6

Circulating levels of the antiangiogenic marker soluble FMS-like tyrosine kinase 1 are elevated in women with pregestational diabetes and preeclampsia: angiogenic markers in preeclampsia and preexisting diabetes.

Cohen A, Lim KH, Lee Y, Rana S, Karumanchi SA, Brown F. Cohen A, et al. Among authors: karumanchi sa. Diabetes Care. 2007 Feb;30(2):375-7. doi: 10.2337/dc06-1514. Diabetes Care. 2007. PMID: 17259514 No abstract available.

7

Cytomegalovirus-induced mirror syndrome associated with elevated levels of circulating antiangiogenic factors.

Rana S, Venkatesha S, DePaepe M, Chien EK, Paglia M, Karumanchi SA. Rana S, et al. Among authors: karumanchi sa. Obstet Gynecol. 2007 Feb;109(2 Pt2):549-52. doi: 10.1097/01.AOG.0000248538.03280.cf. Obstet Gynecol. 2007. PMID: 17267891

8

Sequential changes in antiangiogenic factors in early pregnancy and risk of developing preeclampsia.

Rana S, Karumanchi SA, Levine RJ, Venkatesha S, Rauh-Hain JA, Tamez H, Thadhani R. Rana S, et al. Among authors: karumanchi sa. Hypertension. 2007 Jul;50(1):137-42. doi: 10.1161/HYPERTENSIONAHA.107.087700. Epub 2007 May 21. Hypertension. 2007. PMID: 17515455

9

Diagnostic utility of soluble fms-like tyrosine kinase 1 and soluble endoglin in hypertensive diseases of pregnancy.

Salahuddin S, Lee Y, Vadnais M, Sachs BP, Karumanchi SA, Lim KH. Salahuddin S, et al. Among authors: karumanchi sa. Am J Obstet Gynecol. 2007 Jul;197(1):28.e1-6. doi: 10.1016/j.ajog.2007.04.010. Am J Obstet Gynecol. 2007. PMID: 17618745 Clinical Trial.

10

Circulating concentrations of soluble endoglin (CD105) in fetal and maternal serum and in amniotic fluid in preeclampsia.

Staff AC, Braekke K, Johnsen GM, Karumanchi SA, Harsem NK. Staff AC, et al. Among authors: karumanchi sa. Am J Obstet Gynecol. 2007 Aug;197(2):176.e1-6. doi: 10.1016/j.ajog.2007.03.036. Am J Obstet Gynecol. 2007. PMID: 17689641

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

362 results

Search Page

Filters